Humana has become the latest insurer to be sued over allegedly using artificial intelligence to deny care, with a class action lawsuit claiming the company’s nH Predict AI model was used to deny care to Medicare Advantage members. The lawsuit accuses Humana of cutting payments prematurely for rehabilitative care based on nH Predict’s “highly inaccurate” […]
PharmStars offers startups a 10-week digital health accelerator program with the latest focused on the challenges of supply delivery, says CEO and founder Naomi Fried.
In a final rule on fees for disputed claims, Health and Human Services and other departments are finalizing an amount of $115 per party for disputes initiated on or after the effective date of this rule on January 1, 2024. The departments are also finalizing a certified IDR entity fee range of $200-$840 for single […]
Medicare beneficiaries aren’t getting the treatments they need for opioid use disorder and many are dying due to fentanyl, with fewer than one in five enrollees receiving medication to treat their disorder, according to a new report from the Department of Health and Human Services.
The American Medical Association recently released principles for AI development and deployment as a way to engage with Congress, says AMA President Dr. Jesse Ehrenfeld, speaking during the HIMSS AI in Healthcare Forum.
The Kroger grocery store chain, which as Kroger Health operates over 2,200 pharmacies across 35 states, is partnering with Better Health Group to offer value-based primary care to seniors enrolled in Medicare. This marks Kroger’s and The Little Clinic’s entrance into value-based care.
Artificial intelligence gives the capacity for larger cohorts, as well as more attributes and decision points around patients, says Updesh Dosanjh, practice leader, Technology Solutions for IQVIA.
The Centers for Disease Control and Prevention is closely monitoring JN.1, currently the fastest-growing COVID-19 variant in the U.S., representing about 21% of new cases, according to the agency’s numbers.
Dozens of pharmaceutical companies will be required to pay rebates to Medicare for price hikes on prescription drugs that went against the mandate of the Inflation Reduction Act, the Biden Administration announced yesterday.
Twenty-eight provider and payer organizations have made voluntary commitments to move toward the safe, secure and trustworthy purchasing and use of AI technology, as outlined in President Biden’s Executive Order issued in October, according to the Department of Health and Human Services.